GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Jubilant Pharmova Ltd

Jubilant Pharmova Board Meeting Nov 13, 2026 to Review Q2 FY27 Results

BOARD ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 30 Oct 2026, 05:18 PM IST  ·  BSE ID: c3b0c992-c0e2-4ab5-996c-0d67500a93c9
View Original BSE Filing (PDF)
💡
In Simple Terms
Jubilant Pharmova will announce its latest financial results to shareholders in a board meeting on November 13, 2026.
🤖 AI Summary
  • Jubilant Pharmova Board meeting scheduled for November 13, 2026.
  • Purpose: Consider unaudited standalone and consolidated financial results.
  • Period covered: Quarter and half-year ended September 30, 2026.
  • Disclosure complies with SEBI Listing Regulations, 2015.
🏢 How This Affects the Company
💰
Financial Impact
The upcoming announcement will provide clarity on the company's financial performance for the second quarter and first half of the current fiscal year.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders at this time.
👤
Who Is Affected
All shareholders of Jubilant Pharmova will be informed of the company's financial performance through the announced results.
🔍
Management Signal
The board's meeting signals adherence to regular financial reporting and disclosure norms.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Jubilant Pharmova Q2 FY27 standalone financial results.
Jubilant Pharmova Q2 FY27 consolidated financial results.
Confirmation of the November 13, 2026, board meeting outcome.
LOW RISK This is a routine disclosure of upcoming financial results.
💡 Investor Takeaway
Jubilant Pharmova's Board will meet on November 13, 2026, to approve unaudited financial results for the quarter and half-year ended September 30, 2026.
❓ Frequently Asked Questions
When is the Jubilant Pharmova Board meeting scheduled?
The meeting of the Board of Directors of Jubilant Pharmova is scheduled for Friday, November 13, 2026.
What will be discussed at the Jubilant Pharmova Board meeting on November 13, 2026?
The board will consider the unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026.
Which financial period do the upcoming Jubilant Pharmova results cover?
The upcoming financial results will cover the quarter and half-year ended September 30, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.